Masha Maharaj | Nuclear | Best Researcher Award

Published on by Academic Achievements

Dr. Masha Maharaj | Nuclear | Best Researcher Award

Dr. Masha Maharaj | Nuclear – Head of Department at Umhlanga Molecular Imaging and Therapy, South Africa

Dr. Masha Maharaj is a distinguished researcher known for her groundbreaking contributions to her field. With a keen analytical mind and a passion for innovation, she has dedicated her career to advancing knowledge and fostering scientific progress. Her work has been instrumental in addressing complex challenges, and she has been recognized for her outstanding achievements through numerous accolades. Driven by curiosity and a commitment to excellence, Dr. Maharaj continues to push the boundaries of research, making significant contributions that impact both academia and industry.

Professional Profile

ORCID

Education

Dr. Maharaj’s academic journey is marked by excellence and dedication. She earned her doctoral degree from a prestigious institution, where she specialized in cutting-edge research that laid the foundation for her future work. Her academic achievements have been complemented by various advanced certifications and training programs that have further honed her expertise. She has always been committed to lifelong learning, ensuring that she remains at the forefront of developments in her field. Through her academic pursuits, Dr. Maharaj has developed a deep understanding of theoretical and applied aspects of her discipline.

Experience

With extensive experience spanning multiple years, Dr. Maharaj has held key positions in academia, research institutions, and industry collaborations. She has worked as a lead researcher, faculty member, and consultant, contributing significantly to various projects of national and international importance. Her expertise has led her to work with renowned organizations, where she has played a pivotal role in developing innovative solutions and pioneering new methodologies. In addition to her research endeavors, Dr. Maharaj has mentored numerous students and early-career researchers, shaping the next generation of scientific minds.

Research Interests

Dr. Maharaj’s research interests encompass a broad range of topics that are vital to advancements in her field. Her work focuses on innovative problem-solving approaches, integrating interdisciplinary methods to address pressing scientific and technological challenges. She has contributed significantly to the understanding of complex systems, offering novel insights that have influenced policy, industry practices, and academic discourse. Her research is driven by a passion for discovery and a relentless pursuit of solutions that benefit society. She is particularly interested in harnessing emerging technologies to drive impactful change and improve outcomes in various domains.

Awards and Recognitions

Dr. Maharaj’s contributions have been widely acknowledged through numerous awards and recognitions. She has received prestigious accolades for her research excellence, including best paper awards, innovation prizes, and distinguished fellowships. Her work has been highlighted at major conferences, and she has been invited to deliver keynote addresses at leading academic and industry forums. Additionally, her contributions have earned her memberships in esteemed professional organizations, further underscoring her impact and influence in the field. These recognitions serve as a testament to her dedication and the profound significance of her work.

Publications

  • “Is Extraordinary Response and Long-Term Remission of Metastatic Castration-Resistant Prostate Cancer (mCRPC) After [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy Due to an Immunomodulatory Effect (Radiovaccination)? A Dual Center Experience on Super-Responders.”
  • “Exceptional response of rare Plasmacytoid variant Prostate Cancer post 4 cycles Lu177 PSMA therapy seen on Ga68 PSMA PET/CT.”
  • “Atypical primary sclerosing cholangitis (PSC) findings on a Tc-99m Mebrofenin scan.”
  • “The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: A WARMTH multicentre study.”
  • “The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer—a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report.”
  • “Pre-Therapeutic Prognostic Factors of Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients treated with 177Lu-PSMA-617. A WARMTH Multicenter Study (The 617 Trial).”
  • “The impact of prior therapies on overall survival in mCRPC patients receiving Lu-PSMA-617 therapy. A WARMTH retrospective multicenter trial.”

Conclusion

Dr. Masha Maharaj is an exemplary researcher whose work has made a lasting impact in her field. Her dedication to advancing knowledge, coupled with her extensive experience and research excellence, makes her a strong candidate for the Best Researcher Award. Through her pioneering research, mentorship, and commitment to innovation, she continues to shape the future of her discipline. Recognized globally for her contributions, Dr. Maharaj remains a leading force in scientific exploration and development. Her work not only enriches the academic community but also drives meaningful change in real-world applications. This nomination serves as a tribute to her remarkable achievements and the invaluable contributions she has made to research and innovation.

 

Imam Kambali | Nuclear Science and Engineering | Best Researcher Award

Published on by Academic Achievements

Dr . Imam Kambali | Nuclear Science and Engineering | Best Researcher Award 

Researcher , National Research and Innovation Agency of Indonesia (Badan Riset dan Inovasi Nasional, BRIN) , Indonesia.

Dr. Imam Kambali is a researcher at the National Research and Innovation Agency (BRIN) of Indonesia, specializing in nuclear physics, nuclear engineering, and accelerator applications. His work primarily focuses on the production of radioisotopes using both cyclotron and reactor-based methods. Dr. Kambali has made significant contributions to the field through his research on proton-induced nuclear reactions and secondary neutron irradiation. His career includes extensive involvement in the development of advanced technologies for nuclear medicine and diagnostics.

Profile

Scopus

Education

Dr. Kambali earned his Ph.D. in Physics from University College Dublin, National University of Ireland, where he worked under the guidance of Prof. Gerry O’Sullivan and Prof. Padraig Dunne. He obtained his Master of Philosophy in Physics from the University of Newcastle, Australia, supervised by Prof. John O’Connor and Prof. Bruce King. He holds a Bachelor’s degree in Nuclear Engineering from Gadjah Mada University, Indonesia, where he was mentored by Dr.-Ing. Kusnanto and Drs. Tjipto Sujitno.

Experience

Dr. Kambali’s professional career began at Indonesia’s National Nuclear Energy Agency (BATAN) where he worked as a researcher from 2014 to 2021. He then transitioned to the National Research and Innovation Agency (BRIN) where he continues to lead research on nuclear technologies. He is also a member of multiple prestigious organizations, including the Indonesian Researcher Union and the Physical Society of Indonesia, reflecting his dedication to advancing nuclear science.

Research Interests

Dr. Kambali’s research focuses on nuclear physics, particularly the production of radioisotopes for medical and industrial applications. He is involved in both cyclotron and reactor-based methods of radioisotope production, with special attention to proton-induced nuclear reactions. His work has contributed to advancements in positron emission tomography (PET) imaging and the development of novel diagnostic tools in nuclear medicine.

Awards

Dr. Kambali has been recognized for his contributions to nuclear science through numerous awards and accolades throughout his career. His work on the development of radioisotope production methods has been celebrated both in Indonesia and internationally, highlighting his influence on nuclear medicine and accelerator technology research.

Publications

Dr. Kambali has published extensively in high-impact journals. Some of his notable publications include:

  • Development of target holder for the first experiment on an alternative route for 64Cu radioisotope production – Nuclear Science and Engineering, 2024. (Cited by)
  • Preliminary Study on Tandem Electrostatic Accelerator for The Ion Accelerator Facility – AIP Conference Proceedings, 2024.
  • Cerium-139 Radionuclide Production from Proton-Induced Nuclear Reaction – AIP Conference Proceedings, 2024.
  • Optimum radioactivity yield of Zirconium-89 radionuclide applicable for radioimmuno-PET imaging – Journal of Physics, 2023.
  • Construction and Building Materials – 2023, (Cited by).

Conclusion

Dr. Imam Kambali’s exceptional research contributions, particularly in nuclear physics and radiopharmaceuticals, make him a strong candidate for the Best Researcher Award. His work’s impact on medical diagnostics, coupled with a strong publication record and international exposure, highlights his dedication to advancing nuclear science. Further broadening his research’s interdisciplinary scope and increasing his leadership in professional organizations could amplify his already significant contributions.